Bacterial Infections news from FierceHealthcare
NewsBeth Israel safety lapses raise concern among state regulators
Ordinarily, Beth Israel Deaconess Medical Center has a sterling reputation for appropriate care. However, some cleanliness concerns raised by a recent state inspection may have lowered that Read more...
| Press ReleasesCubist Announces First Patient Dosed in Pivotal Global Phase 3 Trial of CXA-201 for Complicated Intra-Abdominal InfectionsLEXINGTON, Mass.--(BUSINESS WIRE)-- Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the initiation of a pivotal Phase 3 trial of CXA-201 (ceftolozane/tazobactam) in patients with Read more >> Baxter Submits European Marketing Authorization Application For HyQ, an Investigational IG Therapy for Primary ImmunodeficVIENNA--(BUSINESS WIRE)-- Baxter International Inc. announced today that it has submitted an application to the European Medicines Agency’s Committee for Human Medicinal Products seeking marketing Read more >> Garamycin® Ophthalmic Solution Now Available from Fera PharmaceuticalsNEW YORK--(BUSINESS WIRE)-- Fera Pharmaceuticals announced the launch today of Garamycin (gentamicin sulfate) Ophthalmic Solution USP. Garamycin Ophthalmic Solution, a broad spectrum anti-infective, Read more >> MicroPhage Awarded $978,000 for Development of Bacterial Diagnostic TestsLONGMONT, Colo.--(BUSINESS WIRE)-- MicroPhage, Inc. announced today that it has received two Qualifying Therapeutic Discovery Project (QTDP) grants totaling $977,916 from the IRS. The grants, awarded Read more >> MicroPhage Awarded $978,000 for Development of Bacterial Diagnostic TestsLONGMONT, Colo.--(BUSINESS WIRE)-- MicroPhage, Inc. announced today that it has received two Qualifying Therapeutic Discovery Project (QTDP) grants totaling $977,916 from the IRS. The grants, awarded Read more >> |
